Skip to Main Content

Author Details

David M Jablons
University of California, USA Cardiovascular Research Institute san francisco
1981
267
62
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36827975SARS-CoV-2 infection of airway organoids reveals conserved use of Tetraspanin-8 by Ancestral, Delta, and Omicron variants.Stem Cell Reports2023
37121213Comparative genomics between matched solid and lepidic portions of semi-solid lung adenocarcinomas.Lung Cancer2023
37126944Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer.J Clin Oncol2023
36342456MK256 is a novel CDK8 inhibitor with potent antitumor activity in AML through downregulation of the STAT pathway.Oncotarget2022
33107354Ponatinib is a potential therapeutic approach for malignant pleural mesothelioma.Exp Lung Res2021
33908819Extracellular sulfatases as potential blood-based biomarkers for early detection of lung cancer.Exp Lung Res2021
33572297Bioinformatic Approaches to Validation and Functional Analysis of 3D Lung Cancer Models.Cancers (Basel)2021
33728541Resectability, Recurrence, and Risk Stratification of Giant Solitary Fibrous Tumors in the Thoracic Cavity.Ann Surg Oncol2021
33613845A novel isoform of Homeodomain-interacting protein kinase-2 promotes YAP/TEAD transcriptional activity in NSCLC cells.Oncotarget2021
34880292Genetic and immunologic features of recurrent stage I lung adenocarcinoma.Sci Rep2021
34435876Improved outcomes and staging in non-small-cell lung cancer guided by a molecular assay.Future Oncol2021
34544620Molecular Risk Stratification is Independent of EGFR Mutation Status in Identifying Early-Stage Non-Squamous Non-Small Cell Lung Cancer Patients at Risk for Recurrence and Likely to Benefit From Adjuvant Chemotherapy.Clin Lung Cancer2021
34100012SARS-CoV-2 infection studies in lung organoids identify TSPAN8 as novel mediator.bioRxiv2021
31851005Perioperative Lung Resection Outcomes After Implementation of a Multidisciplinary, Evidence-based Thoracic ERAS Program.Ann Surg2021
33276062Development of novel monoclonal antibodies and immunoassays for sensitive and specific detection of SULF1 endosulfatase.Biochim Biophys Acta Gen Subj2021
30907630Applications of Next-Generation Sequencing in Neoantigen Prediction and Cancer Vaccine Development.Genet Test Mol Biomarkers2020
31755214Inhibition of cyclin-dependent kinase 7 down-regulates yes-associated protein expression in mesothelioma cells.J Cell Mol Med2020
32997124Evaluation of a National Comprehensive Cancer Network Guidelines-Based Decision Support Tool in Patients With Non-Small Cell Lung Cancer: A Nonrandomized Clinical Trial.JAMA Netw Open2020
32822576Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing.Cell2020
32905466AMXI-5001, a novel dual parp1/2 and microtubule polymerization inhibitor for the treatment of human cancers.Am J Cancer Res2020
32206574Surgery for pleural mesothelioma, when it is indicated and why: arguments against surgery for malignant pleural mesothelioma.Transl Lung Cancer Res2020
32466572The Crosstalk between Src and Hippo/YAP Signaling Pathways in Non-Small Cell Lung Cancer (NSCLC).Cancers (Basel)2020
30553716Pathologic Complete Response to Neoadjuvant Crizotinib in a Lung Adenocarcinoma Patient With a MET Exon 14 Skipping Mutation.Clin Lung Cancer2019
31686913Differential gene expression identifies KRT7 and MUC1 as potential metastasis-specific targets in sarcoma.Cancer Manag Res2019
31387256Epidermal Growth Factor Receptor (EGFR) Pathway, Yes-Associated Protein (YAP) and the Regulation of Programmed Death-Ligand 1 (PD-L1) in Non-Small Cell Lung Cancer (NSCLC).Int J Mol Sci2019
31488186Case report: recurrent metastatic breast cancer in internal mammary dissection bed discovered at the time of coronary bypass.J Cardiothorac Surg2019
31233205Cucurbitacin E inhibits the Yesâ¿¿associated protein signaling pathway and suppresses brain metastasis of human nonâ¿¿small cell lung cancer in a murine model.Oncol Rep2019
31283845Mesothelioma: Scientific clues for prevention, diagnosis, and therapy.CA Cancer J Clin2019
31341017The crystal structure of the protein kinase HIPK2 reveals a unique architecture of its CMGC-insert region.J Biol Chem2019
31052599Cul4A Modulates Invasion and Metastasis of Lung Cancer Through Regulation of ANXA10.Cancers (Basel)2019
30959120Incorporation of a Molecular Prognostic Classifier Improves Conventional Non-Small Cell Lung Cancer Staging.J Thorac Oncol2019
28645632Adjuvant Chemotherapy Guided by Molecular Profiling and Improved Outcomes in Early Stage, Non-Small-Cell Lung Cancer.Clin Lung Cancer2018
29999500Expansion of hedgehog disrupts mesenchymal identity and induces emphysema phenotype.J Clin Invest2018
29966799Scientific Advances and New Frontiers in Mesothelioma Therapeutics.J Thorac Oncol2018
29844800Transfer of multiple loci of donor's genes to induce recipient tolerance in organ transplantation.Exp Ther Med2018
30464882Central Airway Obstruction Due to Tracheal Glomus Tumor.Thorac Cardiovasc Surg Rep2018
30544524The Role of Yes-Associated Protein (YAP) in Regulating Programmed Death-Ligand 1 (PD-L1) in Thoracic Cancer.Biomedicines2018
29581874Old Sonic Hedgehog, new tricks: a new paradigm in thoracic malignancies.Oncotarget2018
29581846Preclinical characterization of therapeutic antibodies targeted at the carboxy-terminus of Sonic hedgehog.Oncotarget2018
29575535Inhibition of yes-associated protein down-regulates PD-L1 (CD274) expression in human malignant pleural mesothelioma.J Cell Mol Med2018
29575527Inhibition of yes-associated protein suppresses brain metastasis of human lung adenocarcinoma in a murine model.J Cell Mol Med2018
27911857YAP1 regulates ABCG2 and cancer cell side population in human lung cancer cells.Oncotarget2017
28363369Management of Lung Cancer Invading the Superior Sulcus.Thorac Surg Clin2017
28403238Mobile Genome Express (MGE): A comprehensive automatic genetic analyses pipeline with a mobile device.PLoS One2017
28470935Targeting YAP in malignant pleural mesothelioma.J Cell Mol Med2017
29416661Gli is activated and promotes epithelial-mesenchymal transition in human esophageal adenocarcinoma.Oncotarget2017
29383103YAP regulates PD-L1 expression in human NSCLC cells.Oncotarget2017
29262597Membrane-bound full-length Sonic Hedgehog identifies cancer stem cells in human non-small cell lung cancer.Oncotarget2017
28560410DCLK1 is correlated with MET and ERK5 expression, and associated with prognosis in malignant pleural mesothelioma.Int J Oncol2017
28642587Systematic comparison of two whole-genome amplification methods for targeted next-generation sequencing using frozen and FFPE normal and cancer tissues.Sci Rep2017
  • 1 - 50 of 267

Recommended Authors

UPMC Hillman Cancer Center
Career Start Year 2012
Number of shared co-authors 4
Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School
Career Start Year 2012
Number of shared co-authors 2
University of North Carolina at Chapel Hill
Career Start Year 2009
Number of shared co-authors 5
National Cancer Center Exploratory Oncology Research & Clinical Trial Center
Career Start Year 2008
Number of shared co-authors 2
University of Pisa
Career Start Year 2006
Number of shared co-authors 1
Yonsei Cancer Center, Yonsei University College of Medicine
Career Start Year 2005
Number of shared co-authors 3
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 6
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 2
Peking University Cancer Hospital & Institute
Career Start Year 2002
Number of shared co-authors 2
Washington University School of Medicine
Career Start Year 2000
Number of shared co-authors 4
The University of Manchester
Career Start Year 2000
Number of shared co-authors 6
Yamagata Prefectural Central Hospital
Career Start Year 1998
Number of shared co-authors 2
St Vincent's Hospital
Career Start Year 1997
Number of shared co-authors 2
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1997
Number of shared co-authors 2
Uppsala University
Career Start Year 1997
Number of shared co-authors 0
Mayo Clinic
Career Start Year 1996
Number of shared co-authors 5
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1996
Number of shared co-authors 3
Olivia Newton-John Cancer Research Institute
Career Start Year 1993
Number of shared co-authors 3
Research Institute in Oncology and Hematology
Career Start Year 1991
Number of shared co-authors 1
The First Hospital and College of Basic Medical Sciences, China Medical University
Career Start Year 1990
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 1989
Number of shared co-authors 19
Center for Cancer Research, National Cancer Institute
Career Start Year 1988
Number of shared co-authors 4
David Geffen School of Medicine at university of california los angeles
Career Start Year 1987
Number of shared co-authors 4
Center for Cancer Research, National Cancer Institute
Career Start Year 1985
Number of shared co-authors 3
New York-Presbyterian Hospital
Career Start Year 1983
Number of shared co-authors 5
Siteman Cancer Center, Washington University School of Medicine
Career Start Year 1981
Number of shared co-authors 9
Meyer Cancer Center
Career Start Year 1981
Number of shared co-authors 10
University Health Network, Princess Margaret Cancer Centre
Career Start Year 1977
Number of shared co-authors 8
Duke University Medical Center
Career Start Year 1962
Number of shared co-authors 5

Collaborators

Frederick National Laboratory for Cancer Research
Co-authored papers 21
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 7
University of California san francisco
Co-authored papers 7
University of California san francisco
Co-authored papers 6
University of Colorado School of Medicine
Co-authored papers 5
Guangzhou Medical University, First Hospital
Co-authored papers 5
Kaiser Permanente Northern California, University of California san francisco
Co-authored papers 3
University of California san francisco
Co-authored papers 3
University of California-San Francisco
Co-authored papers 3
University of California san francisco
Co-authored papers 3
University of California San Francisco
Co-authored papers 3
University of California San Francisco
Co-authored papers 3
University of California los angeles
Co-authored papers 3
Co-authored papers 3
Peking University Cancer Hospital
Co-authored papers 2
Injury Prevention Research Center, University of North Carolina
Co-authored papers 2
Co-authored papers 2
Gladstone Institute of Virology
Co-authored papers 2
UCSF Helen Diller Comprehensive Cancer Center
Co-authored papers 2
University of California san francisco
Co-authored papers 2
Cardiovascular Research Institute, University of California san francisco
Co-authored papers 2
Yale School of Medicine
Co-authored papers 2
University of California irvine
Co-authored papers 2
University of California San Francisco
Co-authored papers 2
Co-authored papers 2
Tsinghua University
Co-authored papers 1
University of California san francisco
Co-authored papers 1
Helen Diller Comprehensive Cancer Center, University of California san francisco
Co-authored papers 1
Beth Israel Deaconess Medical Center, Harvard Medical School
Co-authored papers 1
University of California San Francisco
Co-authored papers 1